FDA Approves At-Home Device for Treatment-Resistant Depression

(MedPage Today) — The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker Neurolief announced on Tuesday.
ProlivRx is the first home-based prescription device to deliver focal…

Source link : https://www.medpagetoday.com/psychiatry/depression/119430

Author :

Publish date : 2026-01-14 20:28:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

FDA Approves At-Home Device for Treatment-Resistant Depression

FDA Calls for New Warning on Flu Shots

GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity

Related Posts

AI Tool Rapidly Flags Patients Ineligible for Thrombolysis

Stroke Trial Tips Scale Further to Favor Intra-Arterial Lytic After EVT

WHO Announces Restart of Preventive Cholera Vaccinations After Nearly 4-Year Halt

GLP-1 ‘Agonorexia’; Psychotic Disorders Rising in Young People; Pink Noise Pitfalls

These Aren’t the Ob/Gyn Droids We’re Looking For

Keto Diet Shows Antidepressant Effect in Drug-Resistant Depression

AI Tool Rapidly Flags Patients Ineligible for Thrombolysis

Stroke Trial Tips Scale Further to Favor Intra-Arterial Lytic After EVT

WHO Announces Restart of Preventive Cholera Vaccinations After Nearly 4-Year Halt

GLP-1 ‘Agonorexia’; Psychotic Disorders Rising in Young People; Pink Noise Pitfalls

These Aren’t the Ob/Gyn Droids We’re Looking For

Keto Diet Shows Antidepressant Effect in Drug-Resistant Depression

FDA Removes Warning Page About Dangerous Autism Treatments

VTE During Pancreatic Cancer Care Linked to Worse Survival

Categories

Archives